Placulumab

Placulumab
Monoclonal antibody
Type?
SourceHuman
TargetTNF
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC3404H5262N902O1036S22
Molar mass76104.14 g·mol−1

Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases.[1]

This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued.

References


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.